Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2017 Mar;18(4):327-335.
doi: 10.2217/pgs-2016-0175. Epub 2017 Feb 22.

Assessing feasibility of delivering pharmacogenetic testing in a community pharmacy setting

Susanne B Haga  1 , Jivan Moaddeb  1 , Rachel Mills  1 , Deepak Voora  1
Affiliations
Randomized Controlled Trial

Assessing feasibility of delivering pharmacogenetic testing in a community pharmacy setting

Susanne B Haga et al. Pharmacogenomics. 2017 Mar.

Abstract

Aim: To describe the rationale and design of a study evaluating the delivery of pharmacogenetic (PGx) testing in community pharmacies. Study rationale: Pharmacists have expressed interest in offering PGx testing; however, their lack of knowledge and experience, patients' acceptance and feasibility are unknown in this setting.

Study design: Through a cluster randomized trial, we will assess pharmacist and patient experiences with delivery of PGx testing as a standalone service or integrated into medication therapy management services. Anticipated results: We anticipate that PGx testing can be delivered in a community pharmacy setting and accepted and valued by patients.

Conclusion: This study is expected to provide valuable evidence about the real-world feasibility and acceptance of a community pharmacist-delivered approach of PGx testing.

PubMed Disclaimer

Conflict of interest statement

Financial & competing interests disclosure

This work is supported by the US National Institutes of Health (R01GM081416). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Figures

<b>Figure 1.</b>
Figure 1.. Flowchart of study protocol.
MAP: Medication action plan; MTM: Medication therapy management; PGx: Pharmacogenetic.
See this image and copyright information in PMC

References

    1. Teeter BS, Braxton-Lloyd K, Armenakis AA, Fox BI, Westrick SC. Adoption of a biometric screening service in community pharmacies: a qualitative study. J. Am. Pharm. Assoc. 2014;54(3):258–266. - PubMed
    1. Weidle PJ, Lecher S, Botts LW, et al. HIV testing in community pharmacies and retail clinics: a model to expand access to screening for HIV infection. J. Am. Pharm. Assoc. (2003). 2014;54(5):486–492. - PMC - PubMed
    1. Christensen DB, Farris KB. Pharmaceutical care in community pharmacies: practice and research in the US. Ann. Pharmacother. 2006;40(7–8):1400–1406. - PubMed
    1. National Community Pharmacists Association. Medication adherence in America: a national report. www.ncpanet.org/pdf/reportcard/AdherenceReportCard_Abridged.pdf
    1. Chisholm-Burns MA, Graff Zivin JS, Lee JK, et al. Economic effects of pharmacists on health outcomes in the United States: a systematic review. Am. J. Health Syst. Pharm. 2010;67(19):1624–1634. - PubMed

Publication types

LinkOut - more resources